NASDAQ : FIVN
-$0.06 (-0.2%)
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-06-24 | Rosenblatt | Buy | Buy | Maintain |
| 2026-05-05 | Rosenblatt | Buy | Buy | Maintain |
| 2026-05-01 | Needham | Buy | Buy | Maintain |
| 2026-05-01 | UBS | Buy | Buy | Maintain |
| 2026-05-01 | Barclays | Overweight | Overweight | Maintain |
| 2026-05-01 | Piper Sandler | Neutral | Neutral | Maintain |
| 2026-05-01 | Cantor Fitzgerald | Overweight | Overweight | Maintain |
| 2026-05-01 | DA Davidson | Neutral | Neutral | Maintain |
| 2026-04-21 | Barclays | Overweight | Overweight | Maintain |
| 2026-02-23 | Baird | Neutral | Neutral | Maintain |
| 2026-02-20 | Truist Securities | Buy | Buy | Maintain |
| 2026-02-20 | UBS | Buy | Buy | Maintain |
| 2026-02-20 | RBC Capital | Outperform | Outperform | Maintain |
| 2026-02-20 | Wells Fargo | Equal Weight | Equal Weight | Maintain |
| 2026-02-20 | Rosenblatt | Buy | Buy | Maintain |
| 2026-02-20 | Canaccord Genuity | Buy | Buy | Maintain |
| 2026-02-20 | Evercore ISI Group | Outperform | Outperform | Maintain |
| 2026-02-20 | Cantor Fitzgerald | Overweight | Overweight | Maintain |
| 2026-02-20 | Mizuho | Outperform | Outperform | Maintain |
| 2026-01-15 | Morgan Stanley | Equal Weight | Equal Weight | Maintain |
| 2026-01-12 | Barclays | Overweight | Overweight | Maintain |
| 2026-01-05 | Piper Sandler | Overweight | Neutral | Downgrade |